Yongtao Sun, MD, PhD

Quick facts

Phase 3 pipeline

• cART(TDF/AZT+3TC+LPV/r) · Infectious Diseases
  cART(TDF/AZT+3TC+LPV/r) is a combination antiretroviral therapy that works by inhibiting the replication of HIV.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Yongtao Sun, MD, PhD portfolio CI brief
• Yongtao Sun, MD, PhD pipeline updates RSS